Association of Nasopharynx Cancer with Human Papillomavirus Infections

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Aug 26

PMID 37627110

Authors

Shih-Han Hung

Tzong-Hann Yang

Yen-Fu Cheng

Chin-Shyan Chen

Herng-Ching Lin

Affiliations

Soon will be listed here.

Abstract

This population-based study aims to examine the association between nasopharyngeal carcinoma and human papillomavirus infections. This study included 2747 individuals aged 20 years and older who were diagnosed with nasopharynx cancer as cases and 13,735 propensity-score-matching controls. Multivariate logistic regression models were employed to quantitatively assess the association of nasopharynx cancer with human papillomavirus infections while considering age, sex, monthly income, geographic location, and urbanization level of the patient's residence as well as diabetes, hypertension, and hyperlipidemia. Our chi-squared test indicated a significant dissimilarity in previous human papillomavirus infection rates between nasopharynx cancer patients and controls (12.7% vs. 7.2%, < 0.001). The adjusted odds ratio (OR) for prior human papillomavirus infections was found to be significantly higher for nasopharyngeal carcinoma cases compared to controls at a value of 1.869 with confidence interval ranging from 1.640 to 2.128. Among female participants, compared to controls, the adjusted OR of prior human papillomavirus infections was 2.150 (95% CI = 1.763-2.626) in patients with nasopharynx cancer. In male participants sampled in this study, we observed a statistically significant association between prior human papillomavirus infections and nasopharynx cancer (adjusted OR = 1.689; 95% CI = 1.421-2.008). Our study indicates a noteworthy association between previous human papillomavirus infections and nasopharyngeal carcinoma.

Citing Articles

RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells.

Xu H, Yin Q, Fan L, Zhao Y, Song B, Xu Q Sci Rep. 2025; 15(1):1406.

PMID: 39789198 PMC: 11718199. DOI: 10.1038/s41598-025-85716-6.

Epidemiology of nasopharyngeal carcinoma: current insights and future outlook.

Su Z, Siak P, Lwin Y, Cheah S Cancer Metastasis Rev. 2024; 43(3):919-939.

PMID: 38430391 DOI: 10.1007/s10555-024-10176-9.

Developing a robust two-step machine learning multiclassification pipeline to predict primary site in head and neck carcinoma from lymph nodes.

Liu J, Corti A, Calareso G, Spadarella G, Licitra L, Corino V Heliyon. 2024; 10(2):e24377.

PMID: 38312621 PMC: 10835257. DOI: 10.1016/j.heliyon.2024.e24377.

Association of prostate cancer with human papillomavirus infections: a case-control study.

Yin S, Chung S, Hung S, Liu T, Lin H Prostate Cancer Prostatic Dis. 2023; 27(4):743-748.

PMID: 38092969 DOI: 10.1038/s41391-023-00772-1.

References

Deng Z, Uehara T, Maeda H, Hasegawa M, Matayoshi S, Kiyuna A . Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One. 2014; 9(11):e113702. PMC: 4236156. DOI: 10.1371/journal.pone.0113702. View

Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T . Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci. 2014; 105(4):409-17. PMC: 4317800. DOI: 10.1111/cas.12369. View

Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Dardari R . Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer. 2011; 6(1):3. PMC: 3060847. DOI: 10.1186/1750-9378-6-3. View

Lu Y, Li P, Luo G, Liu D, Zou H . Cancer attributable to human papillomavirus infection in China: Burden and trends. Cancer. 2020; 126(16):3719-3732. DOI: 10.1002/cncr.32986. View

Tham T, Teegala S, Bardash Y, Herman S, Costantino P . Is human papillomavirus and p16 expression associated with survival outcomes in nasopharyngeal cancer?: A systematic review and meta-analysis. Am J Otolaryngol. 2018; 39(6):764-770. DOI: 10.1016/j.amjoto.2018.07.005. View

Chang E, Adami H . The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006; 15(10):1765-77. DOI: 10.1158/1055-9965.EPI-06-0353. View

Raab-Traub N . Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002; 12(6):431-41. DOI: 10.1016/s1044579x0200086x. View

Zhang Y, Fan J, Fan Y, Li L, He X, Xiang Q . The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clin Epigenetics. 2018; 10(1):26. PMC: 6136178. DOI: 10.1186/s13148-018-0459-2. View

Taberna M, Mena M, Pavon M, Alemany L, Gillison M, Mesia R . Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017; 28(10):2386-2398. DOI: 10.1093/annonc/mdx304. View

10.

Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M . Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012; 6 Suppl 1:S104-20. PMC: 3394168. DOI: 10.1007/s12105-012-0368-1. View

11.

Dogan S, Hedberg M, Ferris R, Rath T, Assaad A, Chiosea S . Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2013; 36(4):511-6. PMC: 4656191. DOI: 10.1002/hed.23318. View

12.

Hording U, Nielsen H, Daugaard S, Albeck H . Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope. 1994; 104(1 Pt 1):99-102. DOI: 10.1288/00005537-199401000-00018. View

13.

Mostafaei S, Kazemnejad A, Norooznezhad A, Mahaki B, Moghoofei M . Simultaneous Effects of Viral Factors of Human Papilloma Virus and Epstein-Barr Virus on Progression of Breast and Thyroid Cancers: Application of Structural Equation Modeling. Asian Pac J Cancer Prev. 2020; 21(5):1431-1439. PMC: 7541891. DOI: 10.31557/APJCP.2020.21.5.1431. View

14.

Arbeit J, Howley P, Hanahan D . Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A. 1996; 93(7):2930-5. PMC: 39737. DOI: 10.1073/pnas.93.7.2930. View

15.

Bosch F, Lorincz A, Munoz N, Meijer C, Shah K . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4):244-65. PMC: 1769629. DOI: 10.1136/jcp.55.4.244. View

16.

Chan Y, Lo C, Lau H, Lam T . Vertically transmitted nasopharyngeal infection of the human papillomavirus: does it play an aetiological role in nasopharyngeal cancer?. Oral Oncol. 2014; 50(5):326-9. DOI: 10.1016/j.oraloncology.2013.12.025. View

17.

Tham T, Machado R, Russo D, Herman S, Teegala S, Costantino P . Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16, human papillomavirus (HPV), and Ebstein-Barr virus (EBV). Am J Otolaryngol. 2020; 42(1):102762. DOI: 10.1016/j.amjoto.2020.102762. View

18.

Dawson C, Port R, Young L . The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol. 2012; 22(2):144-53. DOI: 10.1016/j.semcancer.2012.01.004. View

19.

Lo K, Chung G, To K . Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol. 2012; 22(2):79-86. DOI: 10.1016/j.semcancer.2011.12.011. View

20.

Nakanishi Y, Wakisaka N, Kondo S, Endo K, Sugimoto H, Hatano M . Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Cancer Metastasis Rev. 2017; 36(3):435-447. PMC: 5613035. DOI: 10.1007/s10555-017-9693-x. View